Jane J. Zara

Array ( [id] => 4100859 [patent_doc_number] => 06100087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Ribozymes targeted to human CCR5 mRNA' [patent_app_type] => 1 [patent_app_number] => 9/038741 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 3547 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100087.pdf [firstpage_image] =>[orig_patent_app_number] => 038741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082087 [patent_doc_number] => 06054439 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Antisense olignucleotides having tumorigenicity-inhibiting activity' [patent_app_type] => 1 [patent_app_number] => 9/185437 [patent_app_country] => US [patent_app_date] => 1998-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 9397 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054439.pdf [firstpage_image] =>[orig_patent_app_number] => 185437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938342 [patent_doc_number] => 06972171 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-06 [patent_title] => 'Antisense oligonucleotide preparation method' [patent_app_type] => utility [patent_app_number] => 09/341700 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 5 [patent_no_of_words] => 7323 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972171.pdf [firstpage_image] =>[orig_patent_app_number] => 09341700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 773709 [patent_doc_number] => 07001890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination' [patent_app_type] => utility [patent_app_number] => 09/355254 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7859 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001890.pdf [firstpage_image] =>[orig_patent_app_number] => 09355254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679563 [patent_doc_number] => 07083983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Inhibitors of the interaction between P53 and MDM2' [patent_app_type] => utility [patent_app_number] => 09/214371 [patent_app_country] => US [patent_app_date] => 1997-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17157 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083983.pdf [firstpage_image] =>[orig_patent_app_number] => 09214371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322436 [patent_doc_number] => 07517668 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-04-14 [patent_title] => 'Process for the production of protein products in aspergillus' [patent_app_type] => utility [patent_app_number] => 08/435557 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15280 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517668.pdf [firstpage_image] =>[orig_patent_app_number] => 08435557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4070148 [patent_doc_number] => 06069007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Ribozyme cleavage of HIV RNA' [patent_app_type] => 1 [patent_app_number] => 7/798128 [patent_app_country] => US [patent_app_date] => 1991-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 2735 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069007.pdf [firstpage_image] =>[orig_patent_app_number] => 798128 [rel_patent_id] =>[rel_patent_doc_number] =>)